Acute paraquat poisoning: report of a survival case following intake of a potential lethal dose.

When properly used, paraquat (PQ) is a widely used bipyridil herbicide with a good safety record. Most cases of PQ poisoning result from intentional ingestion, with death resulting from hypoxemia secondary to lung fibrosis in moderate to severe poisonings. With high ingestion volumes (>50 mL of a 20% wt/vol formulation), death results from multiple organ failure and cardiovascular collapse within 1 week after intoxication. The present report describes a successful clinical case regarding the intoxication of a 15-year-old girl by a presumed lethal dose of PQ. The adolescent ingested approximately 50 mL of a commercialized concentrate (20% wt/vol of dichloride salt) formulation of PQ. High serum and urinary levels of PQ confirmed the bad prognosis. However, the therapeutic protocol followed in the present clinical case led to a positive outcome. Besides the measures for decreasing PQ absorption and increasing its elimination, other protective procedures were applied in aiming to reduce the production of reactive oxygen species (ROS), to scavenge ROS, to repair ROS-induced lesions, and to reduce inflammation. The status-of-the-art concerning the biochemical and toxicological aspects of PQ poisoning and the pharmacologic basis of the respective treatment is also presented.

[1]  A. Borchert,et al.  Activated charcoal is as effective as fuller's earth or bentonite in paraquat poisoning , 1982, Klinische Wochenschrift.

[2]  S. Okonek,et al.  Efficacy of gut lavage, hemodialysis, and hemoperfusion in the therapy of paraquat or diquat intoxication , 1976, Archives of Toxicology.

[3]  Sae-Yong Hong,et al.  Effect of haemoperfusion on plasma paraquat concentration in vitro and in vivo , 2003, Toxicology and industrial health.

[4]  Ja‐Liang Lin,et al.  Combined methylprednisolone and dexamethasone therapy for paraquat poisoning , 2002, Critical care medicine.

[5]  James F Winchester,et al.  Dialysis and hemoperfusion in poisoning. , 2002, Advances in renal replacement therapy.

[6]  K. Okamoto,et al.  Effect of methylprednisolone-pulse therapy on superoxide production of neutrophils. , 1999, Neurological research.

[7]  J. Drault,et al.  Intoxication grave par le paraquat. Évolution favorable après traitement par acétylcystéine et hémodialyse précoce , 1999 .

[8]  J. Delord,et al.  [Massive paraquat poisoning. Favorable course after treatment with n-acetylcysteine and early hemodialysis]. , 1999, Annales francaises d'anesthesie et de reanimation.

[9]  G. Cappelletti,et al.  APOPTOSIS IN HUMAN LUNG EPITHELIAL CELLS: TRIGGERING BY PARAQUAT AND MODULATION BY ANTIOXIDANTS , 1998, Cell biology international.

[10]  S. Z. Idid,et al.  EFFECTS OF FULLER'S EARTH AND ACTIVATED CHARCOAL ON ORAL ABSORPTION OF PARAQUAT IN RABBITS , 1996, Clinical and experimental pharmacology & physiology.

[11]  J. Lin,et al.  Pulse therapy with cyclophosphamide and methylprednisolone in patients with moderate to severe paraquat poisoning: a preliminary report. , 1996, Thorax.

[12]  G. Burton.  Vitamin E: molecular and biological function , 1994, Proceedings of the Nutrition Society.

[13]  W. Mccune,et al.  Immunosuppressive drug therapy of systemic lupus erythematosus. , 1994, Rheumatic diseases clinics of North America.

[14]  A. Tamir,et al.  N-acetylcysteine delays the infiltration of inflammatory cells into the lungs of paraquat-intoxicated rats. , 1993, Toxicology and applied pharmacology.

[15]  J. Perriëns,et al.  High-Dose Cyclophosphamide and Dexamethasone in Paraquat Poisoning: A Prospective Study , 1992, Human & experimental toxicology.

[16]  L. L. Smith,et al.  Effect of iron chelators on paraquat toxicity in rats and alveolar type II cells. , 1992, The American review of respiratory disease.

[17]  R. Wunderink,et al.  Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. , 1991, Chest.

[18]  P. Houzé,et al.  Prognostic Value of Plasma and Urine Paraquat Concentration , 1987, Human toxicology.

[19]  J. Vale,et al.  Treatment of Paraquat Poisoning in Man: Methods to Prevent Absorption , 1987, Human toxicology.

[20]  J. Rousseau,et al.  ACUTE TRANSVERSE MYELITIS AS PRESENTING NEUROLOGICAL FEATURE OF LYME DISEASE , 1986, The Lancet.

[21]  T. Poon-King,et al.  LEUCOCYTE SUPPRESSION IN TREATMENT OF 72 PATIENTS WITH PARAQUAT POISONING , 1986, The Lancet.

[22]  P. Moldéus,et al.  Lung protection by a thiol-containing antioxidant: N-acetylcysteine. , 1986, Respiration; international review of thoracic diseases.

[23]  Oehme Fw,et al.  A literature review of paraquat toxicity. , 1984 .

[24]  A. Nevitt,et al.  A NEW STATISTICAL APPROACH TO THE PROGNOSTIC SIGNIFICANCE OF PLASMA PARAQUAT CONCENTRATIONS , 1984, The Lancet.

[25]  F. Oehme,et al.  A literature review of paraquat toxicity. , 1984, Veterinary and human toxicology.

[26]  Z. Barzilay,et al.  Paraquat poisoning in a child: vitamin E in amelioration of lung injury. , 1980, Archives of disease in childhood.

[27]  A. Proudfoot,et al.  PARAQUAT POISONING: SIGNIFICANCE OF PLASMA-PARAQUAT CONCENTRATIONS , 1979, The Lancet.

[28]  D. G. Clark.  Inhibition of the absorption of paraquat from the gastrointestinal tract by adsorbents , 1971, British journal of industrial medicine.